Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.

Autor: Vallée A; Department of Biochemistry, Nantes University Hospital, France., Marcq M, Bizieux A, Kouri CE, Lacroix H, Bennouna J, Douillard JY, Denis MG
Jazyk: angličtina
Zdroj: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2013 Nov; Vol. 82 (2), pp. 373-4. Date of Electronic Publication: 2013 Aug 19.
DOI: 10.1016/j.lungcan.2013.08.014
Databáze: MEDLINE